Surgical Consent Process for Trans-obturator Tape Slings.

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine if addition of a handout to the standard consent process for the trans-obturator tape (TOT) mid-urethral sling procedure will improve patients' understanding, recall and satisfaction with their procedure. The information provided in the handout will include the procedure details, the accompanying risks and benefits, as well as the expectations and alternatives to the TOT procedure. The aim of the investigators is to improve and standardize the current process for surgical consent for patients undergoing a mid-urethral sling procedure, specifically the TOT. The investigators hypothesize that addition of a handout will improve patient's preoperative comprehension by an absolute value of 10% compared to the standard consent process. The investigators further hypothesize that the handout will improve patient satisfaction and recall of the surgical procedure details post operatively.

Clinical Trial Description

This is a randomized controlled trial investigating whether adding an informational handout to the standard surgical consent will improve patient understanding, recall and satisfaction with their surgery. The primary outcome will be the patient's knowledge of her surgical details immediately before surgery. The secondary outcomes will be the patient's satisfaction, regret scale and the patient's postoperative knowledge of her surgery details.

A member of the research team will recruit eligible patients at their preoperative clinic visit during the signing of consent for their TOT surgery. Verbal counseling for the TOT surgical consent is the current standard of practice in the investigator's office. After the patient is counseled in the usual fashion and signs the consent for her planned TOT surgery, the patient will be offered participation in the study.

Eligible patients will be consented verbally by the investigators. After enrollment, patients will be randomized using a computer-generated block randomization scheme to allocate participants in a 1:1 ratio; randomization will be stratified by provider.

Participants will be randomized to one of two study arms:

1. Control Group: Participants will receive only the standard verbal TOT surgical consent counseling described above.

2. Intervention Group: Participants will receive the standard verbal TOT surgical consent counseling plus a handout describing their surgical intervention.

All participants will be asked to complete a baseline questionnaire at the enrollment visit. Participants randomized to the control group will be finished with this initial study visit after completing the baseline questionnaire. Participants randomized to the intervention arm will be given a handout describing the TOT procedure, risks and benefits, post-operative recovery and alternative treatment options, as discussed in the verbal surgical consent. The patient will be asked to read the handout and will then be given the handout to take home. The provider will answer any questions the patient has after reviewing the handout.

The next study encounter will occur in the preoperative area immediately prior to surgery. At this time all participants will be asked to complete a second questionnaire with questions similar to those in the baseline questionnaire.

The final study encounter will occur at the post-operative visit that occurs approximately six weeks after surgery. At this visit all participants will be asked to complete a final questionnaire. This questionnaire will be the same as the one administered immediately before surgery. All participants will also be asked to complete an additional questionnaire asking about satisfaction, regret and surgical experience. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02750878
Study type	Interventional
Source	Boston Urogynecology Associates
Contact	Eman Elkadry, MD
Phone	617-354-5452
Email	eelkadry@mah.harvard.edu
Status	Recruiting
Phase	N/A
Start date	November 2015
Completion date	July 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02001714` - Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms	N/A
Not yet recruiting	`NCT00523068` - Pharmacological vs Surgical Treatment for Mixed Incontinence	Phase 4
Completed	`NCT00904969` - A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence	N/A
Completed	`NCT00190814` - Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.	Phase 3
Completed	`NCT00190827` - Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)	Phase 3
Terminated	`NCT00247286` - Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial.	Phase 4
Completed	`NCT01959347` - Combined Treatment for Mixed Incontinence	Phase 3
Completed	`NCT00244296` - To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms	Phase 4
Not yet recruiting	`NCT05570071` - A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI.	N/A
Completed	`NCT02334878` - Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence	Phase 3
Completed	`NCT01382602` - Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study	Phase 3
Completed	`NCT03296462` - Hip External Rotation Physical Therapy Trial	N/A
Completed	`NCT02296099` - Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence	Phase 4
Completed	`NCT02599051` - Transobturator Verus Single Incision Slings	N/A
Completed	`NCT00138749` - An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.	Phase 2
Terminated	`NCT03614611` - Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence	N/A
Completed	`NCT03722719` - The Knack on Female Stress Urinary Incontinence	N/A
Active, not recruiting	`NCT02275728` - Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence	N/A
Terminated	`NCT01358214` - Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape)	N/A
Active, not recruiting	`NCT01323426` - Treatment of Stress Urinary Incontinence by Injection of Autologous Muscle Fibers Into the Urethral Sphincter.	Phase 1/Phase 2